Showing results (1651-1660 of 1,742) with videos related to
Sort By:
Pageof 175
Harm Reduction Journal|July 10, 2012
Harm reduction and law enforcement in Vietnam: influences on street policingMelissa Jardine, Nick Crofts, Geoff Monaghan, et al.Harm Reduction Journal|April 21, 2022
Nucleation increases the visual appeal of lager but does not alter overall likeability or drinking rateDavid M Troy, Olivia M Maynard, Matthew Hickman, et al.Harm Reduction Journal|April 12, 2023
Descriptive study: the novel "full spectrum people-with-opioid-use-disorder care model"Richard Gadomski, Snehal Bhatt, Jessica Gross, et al.Harm Reduction Journal|May 9, 2023
Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative studyFahad Safi, William Rioux, Nathan Rider, et al.Harm Reduction Journal|August 25, 2020
Harm reduction in an emergency response to homelessness during South Africa's COVID-19 lockdownTessa S Marcus, Jan Heese, Andrew Scheibe, et al.Harm Reduction Journal|August 25, 2020
HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post serviceMagally Torres-Leguizamon, Emmanuel G Reynaud, Thomas Néfau, et al.Harm Reduction Journal|April 26, 2023
"The familiar taste of poison": a qualitative study of multi-level motivations for stimulant use in sexual minority men living in South FloridaLeah Davis-Ewart, Ji-Young Lee, Michael Viamonte, et al.Harm Reduction Journal|April 8, 2021
Ethical and legal issues in psychedelic harm reduction and integration therapyBrian Pilecki, Jason B Luoma, Geoff J Bathje, et al.Harm Reduction Journal|April 22, 2021
Hospital admissions and mortality due to complications of injection drug use in two hospitals in Regina, Canada: retrospective chart reviewPolina Tsybina, Sandy Kassir, Megan Clark, et al.Harm Reduction Journal|August 18, 2025
A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settingsKatherine J McLean, Nathan E Kruis, Eric Weintraub, et al.Pageof 175